Skip to main content
Log in

Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis

  • Published:
Albrecht von Graefes Archiv für klinische und experimentelle Ophthalmologie Aims and scope Submit manuscript

Summary

Thirty-eight patients with virologically proven dendritic keratitis were treated using either debridement plus human leukocyte interferon (HLI) or debridement plus human fibroblast interferon (HFI) in a randomized, doubleblind study. We administered one drop of HLI or HFI (1×106 reference units/ml) daily and found no significant difference in the action of either type of interferon.

Zusammenfassung

38 Patienten mit virologisch verifizierter Keratitis dendritica wurden in einer randomisierten Doppelblindstudie entweder mit Abrasio plus Humanleukozyteninterferon (HLI) oder Abrasio plus Humanfibroblasteninterferon (HFI) behandelt. Nur ein Tropfen Interferon (1×106 Einheiten/ml) wurde täglich gegeben. Es fand sich kein signifikanter Unterschied zwischen der Wirkung beider Interferone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cantell, K.: Prospects for clinical use of exogenous interferon. Med. Biol. 55, 69–73 (1977)

    Google Scholar 

  2. Cantell, K., Hirvonen, S., Morgensen, K.E., Pyhälä, L.: Human leukocyte interferon production, purification, stability and animal experiments. In: Waymouth C. (ed.), Proceedings of a Tissue Culture Association Workshop, In Vitro, pp. 35–38, Monograph No 3, Rockville, Maryland (1974)

  3. Dahl, M., Degré, M.: A microassay for mouse and human interferon. Acta Pathol. Microbiol. Scand.; Section B. 80, 863–870 (1972)

    Google Scholar 

  4. Einhorn, S., Strander, H.: Is interferon tissue specific? — Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. J. Gen. Virol. 35, 573–577 (1977)

    Google Scholar 

  5. Havell, E.A., Vilcek, J.: Production of high-titered interferon in cultures of human diploid cells. Antimicrob. Agents Chemother. 2, 476–484 (1972)

    Google Scholar 

  6. Jones, B.R., Coster, D.J., Falcon, M.G., Cantell, K.: Topical therapy of ulcerative herpetic keratitis with human interferon. Lancet, 1976II, 128

  7. Neumann-Haefelin, D., Sundmacher, R., Skoda, R., Cantell, K.: Comparative evaluation of human leukocyte and fibroblast interferon in the prevention of herpes simplex virus keratitis in a monkey model. Infect. Immun. 17, 468–470 (1977)

    Google Scholar 

  8. Sundmacher, R., Cantell, K., Haug, P., Neumann-Haefelin, D.: Role of debridement and interferon in the treatment of dendritic keratitis. Albrecht v. Graefes Arch. klin. Ophthal. 207, 77–82 (1978)

    Google Scholar 

  9. Sundmacher, R., Neumann-Haefelin, D., Cantell, K.: Successful treatment of dendritic keratitis with human leukocyte interferon. A controlled clinical study. Albrecht v. Graefes Arch. klin. exp. Ophthal. 201, 39–45 (1976)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

With support from the Deutsche Forschungsgemeinschaft

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sundmacher, R., Cantell, K., Skoda, R. et al. Human leukocyte and fibroblast interferon in a combination therapy of dendritic keratitis. Albrecht von Graefes Arch. Klin. Ophthalmol. 208, 229–233 (1978). https://doi.org/10.1007/BF00419377

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00419377

Keywords

Navigation